Flagship Ventures Fund 2004 L P - Net Worth and Insider Trading
Flagship Ventures Fund 2004 L P Net Worth
The estimated net worth of Flagship Ventures Fund 2004 L P is at least $400,328 dollars as of 2024-05-29. Flagship Ventures Fund 2004 L P is the 10% Owner of Concert Pharmaceuticals Inc and owns about 32,508 shares of Concert Pharmaceuticals Inc (CNCE) stock worth over $272,092. Flagship Ventures Fund 2004 L P is also the 10% Owner of Tetraphase Pharmaceuticals Inc and owns about 58,289 shares of Tetraphase Pharmaceuticals Inc (TTPH) stock worth over $128,236. Details can be seen in Flagship Ventures Fund 2004 L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Flagship Ventures Fund 2004 L P has not made any transactions after 2014-02-12 and currently still holds the listed stock(s).
Transaction Summary of Flagship Ventures Fund 2004 L P
Flagship Ventures Fund 2004 L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Fund 2004 L P owns 5 companies in total, including Quanterix Corp (QTRX) , T2 Biosystems Inc (TTOO) , and Concert Pharmaceuticals Inc (CNCE) among others .
Click here to see the complete history of Flagship Ventures Fund 2004 L P’s form 4 insider trades.
Insider Ownership Summary of Flagship Ventures Fund 2004 L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QTRX | Quanterix Corp | 2017-12-06 | 10 percent owner |
| TTOO | T2 Biosystems Inc | 2014-08-06 | 10 percent owner |
| CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 10 percent owner |
 | | 2013-09-25 | 10 percent owner |
| | 2013-03-25 | 10 percent owner |
Flagship Ventures Fund 2004 L P Latest Holdings Summary
Flagship Ventures Fund 2004 L P currently owns a total of 2 stocks. Among these stocks, Flagship Ventures Fund 2004 L P owns 32,508 shares of Concert Pharmaceuticals Inc (CNCE) as of February 12, 2014, with a value of $272,092 and a weighting of 67.97%. Flagship Ventures Fund 2004 L P also owns 58,289 shares of Tetraphase Pharmaceuticals Inc (TTPH) as of March 25, 2013, with a value of $128,236 and a weighting of 32.03%.
Latest Holdings of Flagship Ventures Fund 2004 L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNCE | Concert Pharmaceuticals Inc | 2014-02-12 | 32,508 | 8.37 | 272,092 |
| TTPH | Tetraphase Pharmaceuticals Inc | 2013-03-25 | 58,289 | 2.20 | 128,236 |
Holding Weightings of Flagship Ventures Fund 2004 L P
Flagship Ventures Fund 2004 L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Ventures Fund 2004 L P has made a total of 0 transactions in Concert Pharmaceuticals Inc (CNCE) over the past 5 years. The most-recent trade in Concert Pharmaceuticals Inc is the sale of 0 shares on February 12, 2014, which brought Flagship Ventures Fund 2004 L P around $0.
According to the SEC Form 4 filings, Flagship Ventures Fund 2004 L P has made a total of 0 transactions in Tetraphase Pharmaceuticals Inc (TTPH) over the past 5 years. The most-recent trade in Tetraphase Pharmaceuticals Inc is the acquisition of 24,591 shares on March 25, 2013, which cost Flagship Ventures Fund 2004 L P around $3 Million.
Insider Trading History of Flagship Ventures Fund 2004 L P
- 1
Flagship Ventures Fund 2004 L P Trading Performance
GuruFocus tracks the stock performance after each of Flagship Ventures Fund 2004 L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Ventures Fund 2004 L P is 11.46%. GuruFocus also compares Flagship Ventures Fund 2004 L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Ventures Fund 2004 L P within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Ventures Fund 2004 L P's insider trading performs compared to the benchmark.
Performance of Flagship Ventures Fund 2004 L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.08 | | | | | |
| Relative Return to S&P 500(%) | 3.92 | | | | | |
Flagship Ventures Fund 2004 L P Ownership Network
Flagship Ventures Fund 2004 L P Owned Company Details
What does Quanterix Corp do?
Who are the key executives at Quanterix Corp?
Flagship Ventures Fund 2004 L P is the 10 percent owner of Quanterix Corp. Other key executives at Quanterix Corp include Chief Financial Officer Vandana Sriram , CFO and Treasurer Michael A Doyle , and President & Quanterix & Dx Masoud Toloue .
Quanterix Corp (QTRX) Insider Trades Summary
Over the past 18 months, Flagship Ventures Fund 2004 L P made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , and a net purchase of 20,200 shares made by William P Donnelly .
In summary, during the past 3 months, insiders sold 2,500 shares of Quanterix Corp (QTRX) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 20,200 shares were bought by its insiders, resulting in a net purchase of 14,700 shares.
Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quanterix Corp Insider Transactions
Flagship Ventures Fund 2004 L P Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Ventures Fund 2004 L P. You might contact Flagship Ventures Fund 2004 L P via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
